Administrative Measures on Filing for Medical Representatives
On June 5, 2020, CMDE start to collect comments on the Administrative Measures on Filing for Medical Representatives (Trail & Draft). A medical representative hereof refers to a professional who is engaged in the transmission, communication and feedback of pharmaceutical information in China on behalf of a pharmaceutical marketing license holder. This Measures is intended to standardize the practice of medical representatives so if this may impact your business in China, your comments or opinions about the Measures can be submitted by June 19, 2020, via email.
